Rtw Investments
Latest statistics and disclosures from Rtw Investments's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RCKT, IMCR, AXSM, ALNY, MRTX, and represent 33.45% of Rtw Investments's stock portfolio.
- Added to shares of these 10 stocks: SAGE (+$106M), MRTX (+$100M), TSHA (+$53M), APGE (+$46M), ACAD (+$37M), BRKR (+$26M), ALKS (+$25M), SWAV (+$25M), MRUS (+$22M), INSM (+$22M).
- Started 10 new stock positions in APGE, ALUR, SAGE, SWAV, SYK, SGMT, SIEN, ALKS, TSHA, RYZB.
- Reduced shares in these 10 stocks: Horizon Therapeutics (-$103M), , ILMN (-$26M), AXNX (-$25M), MRVI (-$19M), BDTX (-$8.6M), VKTX (-$8.2M), OLK (-$7.2M), PMVP, MRSN.
- Sold out of its positions in BDTX, ISRG, MRVI, MRSN, Horizon Therapeutics.
- Rtw Investments was a net buyer of stock by $299M.
- Rtw Investments has $4.7B in assets under management (AUM), dropping by -9.77%.
- Central Index Key (CIK): 0001493215
Tip: Access up to 7 years of quarterly data
Positions held by Rtw Investments consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Rtw Investments
Rtw Investments holds 67 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Rocket Pharmaceuticals (RCKT) | 7.6 | $362M | 18M | 20.49 |
|
|
Immunocore Hldgs Ads (IMCR) | 6.7 | $316M | 6.1M | 51.90 |
|
|
Axsome Therapeutics (AXSM) | 6.6 | $314M | +4% | 4.5M | 69.89 |
|
Alnylam Pharmaceuticals (ALNY) | 6.3 | $298M | 1.7M | 177.10 |
|
|
Mirati Therapeutics (MRTX) | 6.2 | $295M | +51% | 6.8M | 43.56 |
|
Argenx Se Sponsored Adr (ARGX) | 5.3 | $249M | +5% | 507k | 491.63 |
|
ACADIA Pharmaceuticals (ACAD) | 5.1 | $241M | +18% | 12M | 20.84 |
|
Bruker Corporation (BRKR) | 4.4 | $211M | +14% | 3.4M | 62.30 |
|
Ultragenyx Pharmaceutical (RARE) | 4.1 | $193M | 5.4M | 35.65 |
|
|
Penumbra (PEN) | 3.4 | $163M | 673k | 241.91 |
|
|
Ptc Therapeutics I (PTCT) | 3.4 | $162M | 7.2M | 22.41 |
|
|
Thermo Fisher Scientific (TMO) | 3.1 | $147M | 290k | 506.17 |
|
|
Masimo Corporation (MASI) | 2.8 | $132M | 1.5M | 87.68 |
|
|
Establishment Labs Holdings Ord (ESTA) | 2.6 | $122M | 2.5M | 49.07 |
|
|
Natera (NTRA) | 2.5 | $117M | 2.7M | 44.25 |
|
|
Vericel (VCEL) | 2.3 | $110M | 3.3M | 33.52 |
|
|
Sage Therapeutics (SAGE) | 2.2 | $106M | NEW | 5.1M | 20.58 |
|
Celldex Therapeutics Com New (CLDX) | 2.0 | $95M | 3.5M | 27.52 |
|
|
Protagonist Therapeutics (PTGX) | 1.9 | $90M | 5.4M | 16.68 |
|
|
Cytokinetics Com New (CYTK) | 1.6 | $76M | 2.6M | 29.46 |
|
|
Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.6 | $74M | +4% | 7.1M | 10.30 |
|
10x Genomics Cl A Com (TXG) | 1.3 | $63M | +3% | 1.5M | 41.25 |
|
Taysha Gene Therapies Com Shs (TSHA) | 1.1 | $53M | NEW | 17M | 3.16 |
|
Tarsus Pharmaceuticals (TARS) | 1.1 | $51M | +13% | 2.9M | 17.77 |
|
Health Sciences Acq Corp 2 (OBIO) | 1.0 | $49M | 5.6M | 8.72 |
|
|
Insmed Com Par $.01 (INSM) | 1.0 | $47M | +86% | 1.9M | 25.25 |
|
Merus N V (MRUS) | 1.0 | $47M | +90% | 2.0M | 23.58 |
|
Apogee Therapeutics (APGE) | 1.0 | $46M | NEW | 2.1M | 21.30 |
|
Madrigal Pharmaceuticals (MDGL) | 1.0 | $45M | +39% | 310k | 146.04 |
|
Avidity Biosciences Ord (RNA) | 0.9 | $43M | 6.7M | 6.38 |
|
|
Gh Research Ordinary Shares (GHRS) | 0.7 | $33M | +53% | 3.3M | 10.05 |
|
Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $29M | 500k | 57.00 |
|
|
Fulcrum Therapeutics (FULC) | 0.5 | $26M | -4% | 5.8M | 4.44 |
|
Illumina (ILMN) | 0.5 | $26M | -50% | 188k | 137.28 |
|
Alkermes SHS (ALKS) | 0.5 | $25M | NEW | 889k | 28.01 |
|
Axonics Modulation Technolog (AXNX) | 0.5 | $25M | -50% | 443k | 56.12 |
|
Shockwave Med (SWAV) | 0.5 | $25M | NEW | 124k | 199.10 |
|
Scpharmaceuticals (SCPH) | 0.5 | $24M | 3.3M | 7.12 |
|
|
Roivant Sciences SHS (ROIV) | 0.4 | $18M | 1.6M | 11.68 |
|
|
Stoke Therapeutics (STOK) | 0.4 | $17M | 4.4M | 3.94 |
|
|
Allurion Technologies Com Shs (ALUR) | 0.3 | $15M | NEW | 3.5M | 4.30 |
|
Guardant Health (GH) | 0.3 | $15M | 501k | 29.64 |
|
|
Pmv Pharmaceuticals (PMVP) | 0.3 | $15M | -21% | 2.4M | 6.14 |
|
Urogen Pharma (URGN) | 0.3 | $12M | 858k | 14.01 |
|
|
Cutera (CUTR) | 0.2 | $11M | 1.8M | 6.02 |
|
|
Milestone Pharmaceuticals (MIST) | 0.2 | $10M | 3.3M | 3.10 |
|
|
Acelyrin (SLRN) | 0.2 | $9.9M | 978k | 10.17 |
|
|
Immatics SHS (IMTX) | 0.2 | $9.8M | 845k | 11.58 |
|
|
Outset Med (OM) | 0.2 | $8.8M | 809k | 10.88 |
|
|
Mineralys Therapeutics (MLYS) | 0.2 | $8.8M | 922k | 9.51 |
|
|
Stryker Corporation (SYK) | 0.2 | $7.7M | NEW | 28k | 273.27 |
|
Relmada Therapeutics (RLMD) | 0.1 | $6.4M | 2.1M | 3.00 |
|
|
Immunic (IMUX) | 0.1 | $6.4M | 4.3M | 1.47 |
|
|
Design Therapeutics (DSGN) | 0.1 | $5.9M | +60% | 2.5M | 2.36 |
|
Adicet Bio (ACET) | 0.1 | $5.8M | 4.2M | 1.37 |
|
|
Apyx Medical Corporation (APYX) | 0.1 | $5.7M | 1.8M | 3.20 |
|
|
Dermtech Ord ord (DMTK) | 0.1 | $3.9M | 2.7M | 1.44 |
|
|
Exagen (XGN) | 0.1 | $3.6M | 1.5M | 2.42 |
|
|
Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $3.5M | NEW | 400k | 8.80 |
|
Viking Therapeutics (VKTX) | 0.1 | $2.9M | -74% | 259k | 11.07 |
|
Olink Hldg Ab Sponsored Ads (OLK) | 0.1 | $2.4M | -75% | 164k | 14.75 |
|
Akoya Biosciences (AKYA) | 0.0 | $1.6M | 338k | 4.65 |
|
|
Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.4M | 128k | 10.82 |
|
|
Rayzebio (RYZB) | 0.0 | $1.0M | NEW | 46k | 22.20 |
|
Sientra (SIEN) | 0.0 | $845k | NEW | 304k | 2.78 |
|
Miromatrix Med | 0.0 | $583k | 445k | 1.31 |
|
|
Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $60k | 350k | 0.17 |
|
Past Filings by Rtw Investments
SEC 13F filings are viewable for Rtw Investments going back to 2014
- Rtw Investments 2023 Q3 filed Nov. 14, 2023
- Rtw Investments 2023 Q2 filed Aug. 14, 2023
- Rtw Investments 2023 Q1 filed May 15, 2023
- Rtw Investments 2022 Q4 filed Feb. 14, 2023
- Rtw Investments 2022 Q3 filed Nov. 14, 2022
- Rtw Investments 2022 Q2 filed Aug. 15, 2022
- Rtw Investments 2022 Q1 filed May 16, 2022
- Rtw Investments 2021 Q4 filed Feb. 14, 2022
- Rtw Investments 2021 Q3 filed Nov. 15, 2021
- Rtw Investments 2021 Q2 filed Aug. 13, 2021
- Rtw Investments 2021 Q1 filed May 14, 2021
- Rtw Investments 2020 Q4 filed Feb. 16, 2021
- Rtw Investments 2020 Q3 filed Nov. 16, 2020
- Rtw Investments 2020 Q2 filed Aug. 14, 2020
- Rtw Investments 2020 Q1 filed May 15, 2020
- Rtw Investments 2019 Q4 filed Feb. 14, 2020